Care Quality

SAN DIEGO — In this video exclusive from ASN Kidney Week, Jeffrey Giullian, MD, MBA, FASN, chief medical officer of DaVita, discusses three pressing regulatory issues for nephrology stakeholders.

A new trial center network and two major data collection projects are among recent EULAR initiatives for improved care of patients with rheumatic and musculoskeletal diseases, according to a speaker at the EULAR 2024 Congress.

The American College of Surgeons released updated guidelines promoting lifelong competency and ability assessments for surgeons to enhance patient safety and preserve “physician dignity,” according to a press release.

A survey conducted after the Jan. 4 American Optometric Association’s virtual townhall highlights optometrists’ concerns about anti-patient, anti-doctor and anti-competitive abuses in the vision plan industry.

MIAMI BEACH, Fla. — Dermatologists are often on the forefront of care for many gender-diverse adolescents and can benefit these patients best by fully understanding and listening while providing that care, according to a speaker here.

Quality of care for patients with acute exacerbations of COPD did not improve after the Hospital Readmissions Reduction Program was put in place compared with the period prior to the program’s implementation, according to study results.

Editor’s Note: This interview between Healio and Drs. Philip Robinson and David Liew occurred in September. The editorial staff at Healio had been preparing to publish the resulting Q&A feature during the week of Jan. 2, when they learned of Robinson’s tragic death. We at Healio extend our deepest condolences to his family, friends and colleagues. The original Q&A feature in which Robinson appears is published below.

Lower-cost alternative drugs reduced total costs of care by approximately 5% while maintaining quality care among Medicare beneficiaries with cancer, according to study results presented at ASCO Quality Care Symposium.

Finding that patients in underrepresented groups had similar or better kidney care than white patients, researchers contended differences in care delivery cannot explain observed racial and ethnic disparities in disease progression.

Health care spending and outcomes vary across racial and ethnic groups in the U.S., with underrepresented populations often having higher rates of ED spending and poor or fair health, according to three studies published in JAMA.